<?xml version="1.0" encoding="UTF-8"?>
<p id="para0005">Because of its broad spectrum of action against viruses, including most coronaviruses and particularly its close relative SARS-CoV-1, and because coronavirus cell entry occurs through the endolysosomal pathway 
 <xref rid="bib0048" ref-type="bibr">[48]</xref>, it made sense in a situation of a public-health emergency and the absence of any known efficient therapy to investigate the possible effect of chloroquine against SARS-CoV-2. A recent paper reported that both chloroquine and the antiviral drug remdesivir inhibited SARS-CoV-2 in vitro and suggested these drugs be assessed in human patients suffering from COVID-19 
 <xref rid="bib0049" ref-type="bibr">[49]</xref>.
</p>
